Table of Contents Table of Contents
Previous Page  141 / 398 Next Page
Information
Show Menu
Previous Page 141 / 398 Next Page
Page Background

136

cesses will lead to a better staging protocol and a more tailor-made

treatment for the patient. On this topic we did a review of litera-

ture and we will propose a hypothesis that might lead to a better

understanding of OSCC invading bone.

http://dx.doi.org/10.1016/j.ijom.2017.02.471

Treatment of advanced-stage squamous cell carcinoma of the

head and neck

Y.F. Wang

∗

, H.Y. Yang

Peking University Shenzhen Hospital, China

Background:

The treatment of advanced oral cancer is always a

difficult point.

Objectives:

The aim of this study was to evaluate the usefulness

of salvage surgery by survival rates and life quality in patients with

advanced oral squamous cell carcinoma (OSCC).

Methods:

32 patients with advanced OSCC at stage III or IV

who had received radiotherapy and regular follow-up after sal-

vage combined radical surgery and simultaneous repair between

January 2014 and November 2015 were included in the study. All

patients underwent an interview survey and self-assessment based

on the Chinese version of the University of Washington Quality of

Life Questionnaire (4th edition). Pain, appearance, action, recre-

ation, swallow, chew, language, shoulder function, taste, saliva,

emotion and anxiety were included in this questionnaire.

Findings:

No severe complications occurred and median follow-

up time was 12 months with 100% overall survival, one case

with cervical metastatic, one case with relapses were included.

The quality of life after surgery was pretty much lower, mostly

in swallow, chew, the production of saliva, taste alteration and

defects which made an enormously negative impact on the phys-

iology, emotion, social function and postoperative quality of life

of patients. Simultaneous functional reconstruction improved the

appearance, communication, general condition of patients, which

assisted other treatments like radiotherapy.

Conclusion:

Salvage and radical surgery based sequential com-

bined treatment is an effective treatment program, make a

significant sense to increase the survival rates and functional

reconstruction also improve the quality of life.

http://dx.doi.org/10.1016/j.ijom.2017.02.472

Oral propranolol combined with topical timolol maleate for

the treatment of severe infantile mixed haemangioma in

parotid region

X.K. Wang

School of Stomatology, China Medical University, China

Objective:

To investigate the clinical results and safety of oral

propranolol combined with topical timolol maleate for the man-

agement of severe infantile mixed haemangioma in parotid region.

Methods:

Between October 2012 and June 2014, 52 infants with

severe parotid mixed haemangiomas were treated with a combi-

nation of oral propranolol and topical timolol maleate. All lesions

were also administrated using topically timolol maleate in every

12 h. The therapy duration was planned for 6–8 months or the

two drugs were stopped when complete regression of lesions was

obtained. The blood pressure, heart rate values, and adverse events

were recorded during hospitalisation. The electrocardiogram was

reviewed one month after discharge. The therapeutic outcomes

and safety were assessed by the changes of color, size of tumour,

and adverse effects throughout the course of treatment.

Results:

The mean therapy duration was 5.3 months (range, 3–8

months). Of 52 patients, 37 demonstrated excellent response, 15

showed good response. There was no significant decrease respec-

tively in the mean systolic and diastolic blood pressures and the

mean heart rate from pretreatment to post-treatment (all

P

> 0.05).

The decrease of cardiovascular parameters were not commonly

associated with observable clinical symptoms. No major collateral

effects were observed.

Conclusions:

Oral propranolol combined with topical timolol

maleate are highly effective in the treatment of infantile parotid

mixed haemangioma with minor side effects, and might be used

as the first-line treatment selection.

http://dx.doi.org/10.1016/j.ijom.2017.02.473

An alternative management of the pathological fracture in

osteoradionecrosis

C. Wanis

∗

, S. Nathwani, R. Bunyan

Luton and Dunstable University Hospital Foundation Trust,

United Kingdom

Background:

Osteoradionecrosis (ORN) is a known complication

following therapeutic radiotherapy (RT) in head and neck patients.

ORN was first described by Marx in 1983 as hypovascularity,

hypocellularity, and local tissue hypoxia as a result of radiation

injury

. 1

Methods:

A case report of a 63-year-old male patient with an

ulcerative lesion in the left floor of the mouth. Clinically, histo-

logically and radiographically the lesion represented a T4 N0 M0

SCC. In light of the histological grading of the tumour, and his

immunosuppressed status, adjuvant radiotherapy was instigated

postoperatively.

The patient received implants in the mandible for oral reha-

bilitation. Three years following RT, he developed a pathological

fracture in the left body of mandible. The patient was on the Dela-

nian regime and no surgery was planned due to risks of poor

healing. Instead the implants previously placed in the mandible

were used as external fixation holding the fractured mandible in a

stable position to aid healing.

Results:

The mandibular implants, which coincidentally were on

either side of the fracture, were used to support a splint (kept out

of occlusion) spanning over the fracture site. This stabilised the

fracture site and allowed for complete healing of the fracture.

Conclusion:

This case shows an alternative management of a

pathological fracture. This allowed a medically compromised,

immunosuppressed patient with Grade III ORN to avoid hard tis-

sue graft surgery, and allowed for bony healing of a pathological

fracture.

Reference

Marx, R. E. (1983). Osteoradionecrosis: a new concept of its pathophysiol-

ogy.

J Oral Maxillofac Surg

,

41

, 283–288.

http://dx.doi.org/10.1016/j.ijom.2017.02.474